DYAI is Poised for Explosive Growth as Protein Demand Surges Across Billion-Dollar Markets!
Dyadic Applied BioSolutions (NASDAQ: DYAI) is taking the biotech world by storm with its dual protein production platforms, C1 and Dapibus™, which are designed to serve multiple high-value markets simultaneously.
In healthcare, the company enables faster, more cost-effective production of vaccines, monoclonal antibodies, and cell therapy inputs. In food and nutrition, it is powering the next generation of animal-free dairy proteins and precision fermentation ingredients.
In industrial markets, its enzymes improve sustainability and efficiency across manufacturing, textiles, cleaning, and other applications. DYAI stands out by turning years of research into tangible, revenue-generating solutions, rather than remaining a development-stage company. It’s rare to see a biotech with technology so versatile that it can serve vaccines, biologics, animal-free food, and industrial enzymes from the same platform.
What sets DYAI apart is its ability to commercialize its technology across multiple industries at once.
With products already on the market, a growing portfolio of high-value proteins, and strategic partnerships with research institutions and commercial collaborators worldwide, the company is converting years of platform development into tangible revenue opportunities. From vaccines to sustainable food ingredients, DYAI is positioned to tap into multiple high-growth industries simultaneously.
DYAI has the potential to turn its platform into a global powerhouse, addressing a total protein market that could exceed $1 trillion over time!
How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
Authored by Jeffrey Neal Johnson. Originally Published: 7/7/2026.
Key Points
- TeraWulf signed a 20-year lease with Anthropic that is expected to generate about $19 billion in contracted revenue.
- TeraWulf is selling its 50.1% stake in the Abernathy joint venture to recycle capital into wholly owned AI infrastructure projects.
- Institutional ownership is high, but elevated short interest leaves the stock exposed to sharp moves in either direction.
- Special Report: The company SpaceX cannot operate without
Artificial intelligence is running into a severe physical constraint. Language models are getting exponentially smarter, and chips are processing data faster than ever, but the electrical grid cannot deliver power quickly enough to meet demand. Hyperscalers need multi-gigawatt power feeds and large liquid-cooling systems to train next-generation models, and they want these facilities operational immediately.
Enter the Bitcoin mining sector. For years, cryptocurrency miners have spent billions building high-density energy fortresses in remote locations. Now, operators with the right infrastructure are finding that they already own the exact real estate that artificial intelligence (AI) developers are desperate to secure.
The $19 Billion Jolt: Rewiring the AI Infrastructure Trade
3 AI stocks to buy before August 2026 (Ad)
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005.
Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.
Click here to get all three AI stock names from Alexander GreenTeraWulf Inc. (NASDAQ: WULF) has now provided the clearest proof of concept for this infrastructure crossover thesis. The company recently executed a landmark 20-year lease agreement with artificial intelligence powerhouse Anthropic, securing an estimated $19 billion in contracted revenue over the initial term.
Investors should view this as more than a standard commercial real estate transaction. It marks a fundamental shift in how digital infrastructure operators can monetize stranded power assets. By transitioning from the highly cyclical nature of cryptocurrency mining to utility-grade data center yield, TeraWulf is setting a new operational precedent for the high-performance computing (HPC) sector.
Flipping the Switch: Funding a $19B Hyperscaler Empire
To understand the magnitude of this transition, investors need to look at the mechanics of the Anthropic agreement and how TeraWulf is funding the buildout. The 20-year lease centers on the Justified Data campus in Hawesville, Kentucky, a purpose-built facility designed to handle 401 megawatts of critical IT load.
Management expects to bring the initial capacity online in the second half of 2027, with the full 401 megawatts ramping by early 2028. To put that scale in perspective, traditional enterprise data centers often operate between 10 and 50 megawatts. A 401-megawatt site is a true digital fortress.
Building a facility of this size requires substantial capital expenditure. A look at the balance sheet shows an elevated debt-to-equity ratio of 33.00, a lingering byproduct of rapid infrastructure expansion during previous crypto bull markets. Funding this new Anthropic campus entirely through high-interest debt or heavy equity dilution would have severely penalized current shareholders. Instead, TeraWulf executed a strategic masterclass in capital recycling.
At the same time as the Anthropic announcement, TeraWulf sold its 50.1% interest in the Abernathy Joint Venture to a Fluidstack-led investor group. That divestiture monetizes a 168-megawatt Texas facility for $450 million at a premium to the initial invested capital.
By liquidating a legacy joint venture stake, TeraWulf is generating immediate non-dilutive capital to redeploy directly into the wholly owned Justified Data project. This move eliminates joint-venture accounting constraints and ensures TeraWulf maintains direct operational control over its most lucrative hyperscaler infrastructure.
Upgrading the Circuit: From Block Rewards to AI Yield
This strategic pivot completely rewrites TeraWulf's forward-looking margin profile. Historically, cryptocurrency miners have suffered from brutal margin compression. They are tied to volatile block rewards, unpredictable spot pricing and mandatory hardware refresh cycles after every network halving event. Recent historical earnings reflect those operational challenges, highlighted by a sharp first-quarter 2026 earnings miss and heavily negative trailing net margins.
Hosting enterprise-grade artificial intelligence workloads changes the financial equation entirely. Hyperscalers require the same multi-megawatt grid interconnects and liquid-cooling infrastructure as modern miners, but they pay significantly higher premiums for network stability and guaranteed uptime.
Industry data suggests that high-performance computing workloads yield approximately $149,000 per megawatt month. By comparison, conventional mining operations generate roughly $87,000 per megawatt month.
By locking in a two-decade agreement backed by an investment-grade credit rating, TeraWulf replaces the unpredictable lottery of mining rewards with predictable cash flows. Investors are seeing similar transition attempts across the sector from peers like Core Scientific Inc. (NASDAQ: CORZ) and Iris Energy Ltd. (NASDAQ: IREN), but securing a binding $19 billion commitment from a tier-one developer clearly separates the actual operators from the aspirational ones.
Shock to the System: A High-Voltage Squeeze
The underlying business fundamentals are shifting rapidly, and technical market mechanics are amplifying the bullish narrative. A sharp disconnect exists between institutional positioning and retail short sellers, creating a volatile setup that favors outsized upward price action.
Over the trailing 12 months, smart money has been aggressively accumulating shares.
Recent 13F filings show $991.36 million in institutional inflows versus just $305.12 million in outflows, bringing total institutional ownership to a majority 62.49% of outstanding shares. Investors will also see transparent internal positioning ahead of this catalyst, highlighted by a recent stock retainer grant to Director Walter E. Carter and a structured trading plan established by CEO Paul Prager to navigate the anticipated capacity scaling.
Despite that clear institutional conviction, short interest remains acutely elevated. Currently, 108.7 million shares are sold short, accounting for nearly 28% of the publicly available float. With a days-to-cover ratio of 4.1, bearish traders are highly vulnerable to sudden price spikes.
Short sellers built their thesis on the assumption of continued margin compression and debt distress from legacy mining operations. The sudden realization of $19 billion in contracted high-margin revenue forces a complete reassessment of that bearish outlook.
As TeraWulf begins to book this utility-grade yield, the fundamental repricing of the stock creates significant near-term pressure on those short positions. That could trigger forced covering, adding substantial buying volume to an equity already seeing heavy institutional accumulation.
Plugging Into the Next Generation of Compute
TeraWulf has provided a definitive blueprint for monetizing high-density power assets in the modern digital economy. The transition from cryptocurrency hardware to utility-grade computational real estate structurally derisks the business model while dramatically expanding long-term revenue visibility.
Investors seeking exposure to the physical infrastructure needed to power the next generation of computing may want to add TeraWulf to their watchlist as the initial phases of the Anthropic buildout take shape. As always, execution risk remains a factor in any large-scale development project, particularly the timely deployment of the 401-megawatt infrastructure by 2027. Cautious market participants may prefer to monitor upcoming earnings reports to verify that capital from the Abernathy sale is efficiently flowing into the Kentucky campus before taking a definitive position.
3 Small-Cap Stocks Trading Under $10 With Room to Run
Authored by Bridget Bennett. Originally Published: 7/15/2026.
Key Points
- As mega-cap tech stumbles, analyst James Early recommends Aveanna Healthcare, Genworth Financial, and eGain Corporation as profitable small caps trading under $10 per share.
- Aveanna benefits from insurer demand for home health care, Genworth's mortgage insurance unit offsets a legacy long-term care drag, and eGain is repositioning around AI customer service.
- Despite the appeal of retail investors having an edge over institutions in these smaller names, historical data showing most stocks underperform cash argues for modest position sizing.
- Special Report: The company SpaceX cannot operate without
Big tech is wobbling. The Russell 2000 isn’t.
That split has sent investors searching through smaller names for the kind of value that mega caps stopped offering months ago. James Early, who runs research at Curia Financial and models his stock-picking on Warren Buffett’s approach to durable, cash-generating businesses, highlighted three small-cap stocks trading under $10 a share. Each is profitable and grounded in fundamentals rather than hype.
3 AI stocks to buy before August 2026 (Ad)
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005.
Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.
Click here to get all three AI stock names from Alexander GreenMega-cap tech’s loss has become small-cap America’s gain, and these three names help explain why.
Part of the appeal of a sub-$10 stock is simple math: a few hundred dollars buys far more shares than it would in a $200 name. Fractional shares have made that distinction less important than it once was, but Early’s advice still holds—don’t anchor too much on price alone. What matters is whether the business underneath is worth owning.
Home Health Care Draws Insurer Interest
Aveanna Healthcare Holdings (NASDAQ: AVAH) provides in-home care for complex and expensive patient cases, with Medicare and Medicaid making up roughly 91% of revenue. Home-based care costs a fraction of hospital monitoring, and insurers have taken notice.
Aveanna Healthcare delivered 16% revenue growth over the past year and raised its guidance twice, evidence that demand is outpacing management’s own expectations. The company operates across dozens of U.S. states.
Early sees this as a potential buyout target rather than a moonshot. At a roughly $2 billion market cap, a larger insurer, home health platform, or private equity firm could easily absorb it. The stock has already climbed more than 120% over the past year, but Early argues that run-up matters less for a company this small: institutions can’t buy in size without moving the price, which leaves room for retail investors to get in before Wall Street can.
Healthcare overall has lagged its potential in recent years, overshadowed by AI enthusiasm. But roughly 18% to 19% of U.S. GDP flows through healthcare spending, and an aging population isn’t a trend that quickly reverses. That demand tends to hold up even in a downturn, since medical care is one budget line people don’t cut.
An Ugly Legacy Business Funds a Clean One
Genworth Financial (NYSE: GNW) splits into two very different businesses.
The first is its roughly 82% stake in Enact Holdings (NASDAQ: ACT), which sells private mortgage insurance in a market growing about 8% annually. That segment runs at a 55% net profit margin, funding the second bucket: a closed book of long-term care policies written decades ago and badly underpriced, still costing the company $300 million to $400 million a year.
That drag is finite. Genworth trades at a P/E ratio of 17, below the S&P 500 average, and the stock has climbed steadily over the past five years as the Enact business has carried the load. Early is drawn to exactly this kind of complexity: a company that looks messier from the outside than it performs on the inside.
Growth here won’t be explosive. Early expects something closer to 10% to 12% annually, tracking a mortgage insurance market that grows faster than GDP but isn’t reinventing itself. What Genworth has demonstrated, through both rising and falling rate environments, is that the pivot already worked. The stock hasn’t moved much with rate swings, and Early argues a softer rate environment ahead, with more housing inventory, could help rather than hurt.
A 1990s Survivor Bets on AI
eGain Corporation (NASDAQ: EGAN) has been around since 1997. Founded by Ashu Roy, the customer relationship management software company went public in 1999, then lost nearly all its value before a reverse split kept it listed. It has quietly stayed profitable for decades on $80 million to $90 million in annual revenue.
Now eGain is repositioning itself as an AI customer service platform, and early data is notable: non-AI customer retention is around 101%, while AI-driven retention is near 116%. Clients include the IRS, JPMorgan Chase & Co. (NYSE: JPM), and other large enterprises.
The stock has fallen from roughly $15 a year ago to the mid-single digits, tracking the broader software sell-off as the market debates whether AI helps or hurts software companies. Early argues the labor-intensive nature of customer service makes AI a net positive here, not a threat, and that eGain’s three-decade profitable base offers a floor even if the AI bet takes time to play out. He’s still clear-eyed about the risk: this is a micro-cap that can swing sharply for no obvious reason, and he keeps positions like it small, often under 1% of a portfolio.
The Risk and the Upside
The upside in small caps and micro caps is real: institutions largely can’t compete for shares, leaving retail investors an edge that mostly disappears once a company gets bigger. The risk is real, too, and it’s larger than most investors assume. Research from Arizona State University professor Hendrik Bessembinder, covering nearly a century of U.S. stock market data, found that just 4% of publicly traded companies accounted for all of the market’s net wealth creation above cash returns. The rest, collectively, did no better than holding Treasury bills.
That’s the case for keeping any single small-cap bet modest, no matter how strong the story. Stay disciplined on position size, because that’s what determines whether a good idea turns into a good outcome.
This email is a sponsored email for Smallcaps Daily, a third-party advertiser of DividendStocks.com and MarketBeat.
This message is a paid advertisement for Dyadic Applied BioSolutions (NASDAQ: DYAI) from and Interactive Offers. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $4,500. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either or Interactive Offers. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Dyadic Applied BioSolutions (NASDAQ: DYAI) on Interactive Offers' website for additional information about the relationship between Interactive Offers and Dyadic Applied BioSolutions (NASDAQ: DYAI).
If you need assistance with your account, please contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Pl. #620, Sioux Falls, S.D. 57103. U.S.A..
